Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease.

PubWeight™: 5.09‹?› | Rank: Top 1%

🔗 View Article (PMID 17998437)

Published in Arch Neurol on November 12, 2007

Authors

Hao Li1, Sally Wetten, Li Li, Pamela L St Jean, Ruchi Upmanyu, Linda Surh, David Hosford, Michael R Barnes, James David Briley, Michael Borrie, Natalie Coletta, Richard Delisle, Daniella Dhalla, Margaret G Ehm, Howard H Feldman, Luis Fornazzari, Serge Gauthier, Neil Goodgame, Danilo Guzman, Sandra Hammond, Paul Hollingworth, Ging-Yuek Hsiung, Joan Johnson, Devon D Kelly, Ron Keren, Andrew Kertesz, Karen S King, Simon Lovestone, Inge Loy-English, Paul M Matthews, Michael J Owen, Mary Plumpton, William Pryse-Phillips, Rab K Prinjha, Jill C Richardson, Ann Saunders, Andrew J Slater, Peter H St George-Hyslop, Sandra W Stinnett, Jina E Swartz, Rachel L Taylor, John Wherrett, Julie Williams, David P Yarnall, Rachel A Gibson, Michael C Irizarry, Lefkos T Middleton, Allen D Roses

Author Affiliations

1: GlaxoSmithKline, Research Triangle Park, North Carolina, USA.

Articles citing this

(truncated to the top 100)

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet (2009) 14.86

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07

Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52

Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. Am J Hum Genet (2008) 4.66

Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet (2009) 3.92

Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. Am J Hum Genet (2009) 3.54

Retracted Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease. Nature (2013) 3.35

Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol (2010) 2.91

A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease. Pharmacogenomics J (2009) 2.66

A genome-wide association study for late-onset Alzheimer's disease using DNA pooling. BMC Med Genomics (2008) 2.20

SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer's disease risk. Ann Neurol (2011) 2.01

Genome-wide association study of Alzheimer's disease. Transl Psychiatry (2012) 1.88

Plasma proteins predict conversion to dementia from prodromal disease. Alzheimers Dement (2014) 1.85

Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities. PLoS Genet (2010) 1.80

Performance of genotype imputation for rare variants identified in exons and flanking regions of genes. PLoS One (2011) 1.72

Genome-wide association studies in Alzheimer's disease. Hum Mol Genet (2009) 1.70

Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects. Ann N Y Acad Sci (2008) 1.69

Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals. Arch Neurol (2010) 1.61

Meta-analysis of the association between variants in SORL1 and Alzheimer disease. Arch Neurol (2011) 1.59

The genetics and neuropathology of Alzheimer's disease. Acta Neuropathol (2012) 1.56

The application of naive Bayes model averaging to predict Alzheimer's disease from genome-wide data. J Am Med Inform Assoc (2011) 1.52

Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol Psychiatry (2009) 1.51

Genome-wide association study of alcohol dependence implicates KIAA0040 on chromosome 1q. Neuropsychopharmacology (2011) 1.50

Identification of Rare Variants in ATP8B4 as a Risk Factor for Systemic Sclerosis by Whole-Exome Sequencing. Arthritis Rheumatol (2016) 1.41

Genome-wide scan of copy number variation in late-onset Alzheimer's disease. J Alzheimers Dis (2010) 1.35

Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease. Arch Neurol (2011) 1.34

A comprehensive genetic association study of Alzheimer disease in African Americans. Arch Neurol (2011) 1.33

LDLR expression and localization are altered in mouse and human cell culture models of Alzheimer's disease. PLoS One (2010) 1.32

Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease. PLoS One (2011) 1.32

Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study. BMC Neurol (2010) 1.32

No association between CALHM1 and Alzheimer's disease risk. Cell (2008) 1.30

The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE. Neurobiol Aging (2010) 1.25

A genome-wide association study implicates the APOE locus in nonpathological cognitive ageing. Mol Psychiatry (2012) 1.22

Association of CLU and PICALM variants with Alzheimer's disease. Neurobiol Aging (2010) 1.22

Genetic variation at a single locus and age of onset for Alzheimer's disease. Alzheimers Dement (2010) 1.19

The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. J Alzheimers Dis (2010) 1.19

Apolipoprotein E/C1 locus variants modify renal cell carcinoma risk. Cancer Res (2009) 1.18

Genetics of Alzheimer disease in the pre- and post-GWAS era. Alzheimers Res Ther (2010) 1.18

Collapsing SNP genotypes in case-control genome-wide association studies increases the type I error rate and power. Stat Appl Genet Mol Biol (2008) 1.17

Integrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease risk. Hum Mol Genet (2009) 1.17

Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes. Am J Transl Res (2009) 1.15

GAB2 as an Alzheimer disease susceptibility gene: follow-up of genomewide association results. Arch Neurol (2009) 1.13

Intermediate phenotypes identify divergent pathways to Alzheimer's disease. PLoS One (2010) 1.11

Discovery and Replication of Gene Influences on Brain Structure Using LASSO Regression. Front Neurosci (2012) 1.10

Mammalian P4-ATPases and ABC transporters and their role in phospholipid transport. Biochim Biophys Acta (2012) 1.09

Gene expression levels as endophenotypes in genome-wide association studies of Alzheimer disease. Neurology (2010) 1.08

No association of SORL1 SNPs with Alzheimer's disease. Neurosci Lett (2008) 1.08

An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3. Am J Med Genet B Neuropsychiatr Genet (2009) 1.05

Endophenotypes in normal brain morphology and Alzheimer's disease: a review. Neuroscience (2009) 1.02

Fine mapping of the chromosome 10q11-q21 linkage region in Alzheimer's disease cases and controls. Neurogenetics (2010) 1.02

Investigation of 15 of the top candidate genes for late-onset Alzheimer's disease. Hum Genet (2010) 1.02

Longitudinal modeling of cognitive aging and the TOMM40 effect. Alzheimers Dement (2012) 1.01

Concerted perturbation observed in a hub network in Alzheimer's disease. PLoS One (2012) 1.00

Beta-amyloid oligomers and cellular prion protein in Alzheimer's disease. J Mol Med (Berl) (2009) 0.99

Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet (2010) 0.98

Genetics of late-onset Alzheimer's disease: update from the alzgene database and analysis of shared pathways. Int J Alzheimers Dis (2011) 0.97

Semantically enabling a genome-wide association study database. J Biomed Semantics (2012) 0.97

Alzheimer disease: New light on an old CLU. Nat Rev Neurol (2010) 0.97

Alzheimer's disease: diagnostics, prognostics and the road to prevention. EPMA J (2010) 0.96

P4 ATPases: flippases in health and disease. Int J Mol Sci (2013) 0.95

Association of common KIBRA variants with episodic memory and AD risk. Neurobiol Aging (2010) 0.94

Growth arrest-specific 1 binds to and controls the maturation and processing of the amyloid-beta precursor protein. Hum Mol Genet (2011) 0.94

Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia. J Alzheimers Dis (2010) 0.93

Impact of SORL1 single nucleotide polymorphisms on Alzheimer's disease cerebrospinal fluid markers. Dement Geriatr Cogn Disord (2011) 0.93

Death-associated protein kinase 1 has a critical role in aberrant tau protein regulation and function. Cell Death Dis (2014) 0.93

The neuronal sortilin-related receptor gene SORL1 and late-onset Alzheimer's disease. Curr Neurol Neurosci Rep (2008) 0.92

Golgi phosphoprotein 2 in physiology and in diseases. Cell Biosci (2012) 0.92

NKAIN1-SERINC2 is a functional, replicable and genome-wide significant risk gene region specific for alcohol dependence in subjects of European descent. Drug Alcohol Depend (2013) 0.92

Analysis of Genome-Wide Association Study (GWAS) data looking for replicating signals in Alzheimer's disease (AD). Int J Mol Epidemiol Genet (2009) 0.92

Is Alzheimer's disease a systemic disease? Biochim Biophys Acta (2014) 0.92

Region-specific protein abundance changes in the brain of MPTP-induced Parkinson's disease mouse model. J Proteome Res (2010) 0.91

CALHM1 P86L polymorphism modulates CSF Aβ levels in cognitively healthy individuals at risk for Alzheimer's disease. Mol Med (2011) 0.90

Blood-based biomarkers for Alzheimer's disease: plasma Aβ40 and Aβ42, and genetic variants. Neurobiol Aging (2011) 0.90

Recent insights into the molecular genetics of dementia. Trends Neurosci (2009) 0.90

Control of neural circuit formation by leucine-rich repeat proteins. Trends Neurosci (2014) 0.89

Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: the Cache County Dementia Progression Study. Alzheimers Dement (2013) 0.89

Identification of novel candidate genes for Alzheimer's disease by autozygosity mapping using genome wide SNP data. J Alzheimers Dis (2011) 0.88

Genomic convergence and network analysis approach to identify candidate genes in Alzheimer's disease. BMC Genomics (2014) 0.88

Angiotensins and Alzheimer's disease: a bench to bedside overview. Alzheimers Res Ther (2009) 0.88

Impact of genetic variation in SORCS1 on memory retention. PLoS One (2011) 0.88

Addiction genetics and pleiotropic effects of common haplotypes that make polygenic contributions to vulnerability to substance dependence. J Neurogenet (2009) 0.88

The effects of chronic treatment with mood stabilizers on the rat hippocampal post-synaptic density proteome. J Neurochem (2011) 0.88

The Broad Impact of TOM40 on Neurodegenerative Diseases in Aging. J Parkinsons Dis Alzheimers Dis (2014) 0.88

Practical and analytical aspects of using friend controls in case-control studies: experience from a case-control study of childhood cancer. Paediatr Perinat Epidemiol (2011) 0.87

Function and comorbidities of apolipoprotein e in Alzheimer's disease. Int J Alzheimers Dis (2011) 0.87

Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOEε4 carriers. Neuroimage (2010) 0.86

Association of TTR polymorphisms with hippocampal atrophy in Alzheimer disease families. Neurobiol Aging (2009) 0.86

Genome-wide association study identifies multiple novel loci associated with disease progression in subjects with mild cognitive impairment. Transl Psychiatry (2011) 0.86

ATP5H/KCTD2 locus is associated with Alzheimer's disease risk. Mol Psychiatry (2013) 0.86

GAB2 is not associated with late-onset Alzheimer's disease in Chinese Han. Neurol Sci (2009) 0.86

Genome-wide and gene-based association implicates FRMD6 in Alzheimer disease. Hum Mutat (2012) 0.86

GP73 is upregulated by hepatitis C virus (HCV) infection and enhances HCV secretion. PLoS One (2014) 0.86

The Sorting Receptor SorCS1 Regulates Trafficking of Neurexin and AMPA Receptors. Neuron (2015) 0.85

Association studies of 19 candidate SNPs with sporadic Alzheimer's disease in the North Chinese Han population. Neurol Sci (2011) 0.85

The impact of the human genome project on complex disease. Genes (Basel) (2014) 0.85

Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation. J Neuroinflammation (2012) 0.85

Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes. Front Aging Neurosci (2014) 0.84

Deep sequencing of the LRRK2 gene in 14,002 individuals reveals evidence of purifying selection and independent origin of the p.Arg1628Pro mutation in Europe. Hum Mutat (2012) 0.83

The role of intracellular trafficking and the VPS10d receptors in Alzheimer's disease. Future Neurol (2012) 0.83

Articles by these authors

Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage (2004) 49.54

The diploid genome sequence of an Asian individual. Nature (2008) 46.29

A draft sequence of the rice genome (Oryza sativa L. ssp. indica). Science (2002) 42.78

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med (2003) 26.05

Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage (2006) 23.57

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 21.80

Large recurrent microdeletions associated with schizophrenia. Nature (2008) 20.25

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol (2007) 18.62

The sequence and de novo assembly of the giant panda genome. Nature (2009) 15.76

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15

Genes mirror geography within Europe. Nature (2008) 14.23

Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev (2007) 13.05

Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet (2007) 12.62

Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature (2010) 12.27

TREM2 variants in Alzheimer's disease. N Engl J Med (2012) 11.35

Diverse somatic mutation patterns and pathway alterations in human cancers. Nature (2010) 10.83

Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet (2008) 10.52

Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet (2008) 10.49

Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med (2014) 10.48

Common variants conferring risk of schizophrenia. Nature (2009) 10.37

Wake-up call for British psychiatry. Br J Psychiatry (2008) 10.30

A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement (2009) 10.21

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain (2011) 9.90

TEAD mediates YAP-dependent gene induction and growth control. Genes Dev (2008) 9.88

Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23

Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci U S A (2009) 9.19

Regulation of TORC1 by Rag GTPases in nutrient response. Nat Cell Biol (2008) 8.92

Suppression of inflammation by a synthetic histone mimic. Nature (2010) 8.80

Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol (2010) 8.74

Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered (2002) 8.64

Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature (2011) 8.29

The genome of the cucumber, Cucumis sativus L. Nat Genet (2009) 8.19

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02

An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people. Science (2012) 7.94

The knockout mouse project. Nat Genet (2004) 7.80

ZDOCK: an initial-stage protein-docking algorithm. Proteins (2003) 7.52

Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44

Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet (2009) 7.16

Gene discovery and annotation using LCM-454 transcriptome sequencing. Genome Res (2006) 7.10

The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol (2010) 7.08

Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord (2007) 6.92

A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. Hum Mol Genet (2003) 6.82

Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet (2003) 6.63

The European Nucleotide Archive. Nucleic Acids Res (2010) 6.48

A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement (2008) 6.39

A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry (2012) 6.34

Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine (2009) 6.30

PlasmoDB: the Plasmodium genome resource. A database integrating experimental and computational data. Nucleic Acids Res (2003) 6.19

Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet (2009) 6.13

The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev (2010) 6.05

Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. Am J Hum Genet (2009) 5.98

SNP discovery via 454 transcriptome sequencing. Plant J (2007) 5.92

Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet (2004) 5.83

Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet (2010) 5.78

MicroRNA-mediated conversion of human fibroblasts to neurons. Nature (2011) 5.59

Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52

A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev (2010) 5.38

Alzheimer's disease. Lancet (2011) 5.35

The oyster genome reveals stress adaptation and complexity of shell formation. Nature (2012) 5.30

Synaptic, transcriptional and chromatin genes disrupted in autism. Nature (2014) 5.30

Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum Mol Genet (2007) 5.28

A porous supramolecular architecture from a copper(II) coordination polymer with a 3D four-connected 8(6) net. Inorg Chem (2003) 5.16

Protective variant for hippocampal atrophy identified by whole exome sequencing. Ann Neurol (2015) 5.10

Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet (2002) 5.05

A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet (2009) 5.01

Improvements to services at the European Nucleotide Archive. Nucleic Acids Res (2009) 5.00

Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome. J Exp Med (2007) 4.95

Stability of the regulatory T cell lineage in vivo. Science (2010) 4.89

Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet (2006) 4.80

Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med (2007) 4.80

The Population Reference Sample, POPRES: a resource for population, disease, and pharmacological genetics research. Am J Hum Genet (2008) 4.79

Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet (2008) 4.78

ApoE promotes the proteolytic degradation of Abeta. Neuron (2008) 4.75

Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol (2004) 4.66

Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum Mol Genet (2009) 4.52

The beginning of the end for the Kraepelinian dichotomy. Br J Psychiatry (2005) 4.51

The Kraepelinian dichotomy - going, going... but still not gone. Br J Psychiatry (2010) 4.47

Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA (2007) 4.44

Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch Neurol (2002) 4.42

The Plasmodium genome database. Nature (2002) 4.36

Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood (2003) 3.98